APLT Investor Alert: A Securities Fraud Class Motion Lawsuit Has Been Filed In opposition to Utilized Therapeutics, Inc. (APLT) By Investing.com
Radnor, Pennsylvania--(Newsfile Corp. - January 25, 2025) - The legislation agency of…
Anilkumar Jangili, Director at SpringWorks Therapeutics — Statistical Programming, AI Traits, Compliance, Leadership, and Business Insights – AI Time Journal – Synthetic Intelligence, Automation, Work and Business
On this interview, Anilkumar Jangili, Director of Statistical Programming at SpringWorks Therapeutics,…
Sivakumar Ramakrishnan, Government Director at Vita International Sciences — Statistical Programming, AI in Life Sciences, Leadership, Customized Options, and Transformative Therapeutics – AI Time Journal – Synthetic Intelligence, Automation, Work and Business
Sivakumar Ramakrishnan, Government Director at Vita International Sciences, brings a novel perspective…
KYTX ANNOUNCEMENT: Kessler Topaz Meltzer & Verify, LLP Notifies Traders of a Class Motion Lawsuit Towards Kyverna Therapeutics, Inc. By Investing.com
RADNOR, PA - January 14, 2025 (NEWMEDIAWIRE) - The regulation agency of…
Kyverna Therapeutics, Inc. (KYTX) Shareholder Reminder: Kessler Topaz Meltzer & Verify, LLP Reminds KYTX Traders of Securities Fraud Class Motion Lawsuit By Investing.com
RADNOR, PA - January 12, 2025 (NEWMEDIAWIRE) - The legislation agency of…
ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Utilized Therapeutics, Inc. Traders to Safe Counsel Earlier than Essential Deadline in Securities Class Motion – APLT By Investing.com
New York, New York--(Newsfile Corp. - January 11, 2025) - WHY: Rosen…
Gyre Therapeutics president Ma Songjiang sells $22,336 in inventory By Investing.com
SAN DIEGO—Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), lately offered a…
Soleno Therapeutics senior VP Patricia Hirano sells $138,709 in inventory By Investing.com
Patricia Hirano, Senior Vice President of Regulatory Affairs at Soleno Therapeutics Inc.…
RVNC ALERT: Kirby McInerney LLP Declares the Submitting of a Securities Class Motion on Behalf of Revance Therapeutics, Inc. Traders By Investing.com
New York, New York--(Newsfile Corp. - January 6, 2025) - The regulation…
Monopar Therapeutics units inventory and warrant providing costs By Investing.com
WILMETTE, Sick. - Monopar Therapeutics Inc . (NASDAQ:), a clinical-stage biopharmaceutical firm…
